Laparoscopic sleeve gastrectomy as a primary bariatric procedure: postoperative outcomes.

BACKGROUND AND AIMS: Laparoscopic sleeve gastrectomy is at present the most popular bariatric procedure due to its significant effect on weight loss, resolution of comorbidities and improvement in the quality of life. However, there are not many studies showing its medium and long term efficacy and safety in Eastern Europe. We aim to report the outcomes of laparoscopic sleeve gastrectomy as a primary bariatric procedure from a single surgical department.
METHODS: This is a retrospective analysis of obese patients who underwent laparoscopic sleeve gastrectomy between 2009 - 2016 in our department. Outcomes were analyzed in terms of weight loss, comorbidity resolution and quality of life changes.
RESULTS: A number of 70 patients were included in the study, with a mean age of 47.6 ± 9.8 years. Mean initial Body Mass Index was 47.4 ± 6.4 kg/m2. The mean percentage of excess weight loss during follow-up was 78.2% at 12 months, 80.2%, 76.7%, 74.7%, 72.8%, 73.3%, 74.1%, 67.2%, 64.07%, 69.7% at 24, 36, 48, 60, 72, 84, 96, 108 and 120 months, respectively. Weight regain occurred in 61 (87.1%) patients during the postoperative period. The mean weight regained was 8.1 ± 4.8 kg at 24 months postoperatively. Regarding the quality of life, 83% of patients declared an increase in self-esteem. Resolution of diabetes, arterial hypertension, and obstructive sleep apnea syndrome occurred in 80%, 42.5% and 70.1% of patients respectively.
CONCLUSIONS: Laparoscopic sleeve gastrectomy is an effective procedure, with good outcomes in the medium and long term, although a tendency for weight regain was noted after 2 years. Resolution of comorbidities is comparable with that reported in the literature, namely an improvement of the quality of life.

Background and aims

In the 21st century, obesity represents a public health problem, which is constantly increasing. Worldwide obesity has almost tripled since 1975 and it is estimated that approximately 13% of the adult population has a Body Mass Index (BMI) of 30 kg/m2 or over [1]. Obesity is associated with comorbidities such as diabetes, high blood pressure, sleep apnea, gastroesophageal reflux disease, joint disease and others [2]. Nowadays, this is one of the main public health issues, due to associated comorbidities affecting the quality of life (QoL) and the life expectancy [3].

Bariatric surgery is beneficial in the treatment of obesity and the only one able to maintain long-term weight loss with consequent improvement or remission of obesity-related comorbidities [4].

Laparoscopic sleeve gastrectomy (LSG) is a restrictive bariatric intervention, which involves removal of a portion of the fundus, corpus, and antrum, to create a tubular duct along the lesser curvature [4]. Although initially described as a component of biliopancreatic diversion [5,6], the popularity of LSG has increased, and today it is a stand-alone bariatric procedure, with the largest worldwide use and with effective results both for weight loss and for resolving the main comorbidities associated with obesity [7]. Several advantages linked to this procedure account for its widespread use, including the absence of an intestinal by-pass and the need to perform any intestinal anastomosis [8].

In western European countries and the United States of America, LSG is well known, with published studies [9] evaluating the postoperative outcomes for the medium and long terms. Not the same can be said about Eastern Europe, where fewer reports exist. Moreover, in Eastern Europe, the number of bariatric surgical centers is smaller compared to western countries.

This study aimed to report the medium and long-term postoperative outcomes of LSG from a single surgical department in Romania, analyzing the evolution of weight loss, resolution of comorbidities and increasing QoL.

Methods

Study design

We conducted a retrospective and observational study, based on a survey of obese patients from a university surgical department in Târgu Mureş, Romania, who underwent surgery for obesity – LSG between May 2009 and December 2016. The inclusion criteria were the embodiment of surgery for obesity: BMI >40 kg/m2 or BMI >35 kg/m2 and associated comorbidities. To find out the weight at each point of follow-up, patients were contacted by telephone. Using a questionnaire customized after BAROS (Bariatric Analysis and Reporting Outcome System) [10] and BQLI (Bariatric Quality of Life Index)[11], we additionally assessed the perception of the patients on the improvement of the QoL after bariatric surgery. The weight loss process was analyzed by the BMI change and by the percentages of excess weight loss (%EWL). The excess weight was calculated by extracting the ideal weight (based on a BMI of 25 kg/m2) from the preoperative weight. The %EWL was calculated according to the formula: [100 x (preoperative weight - current weight)/excess weight]. Also, the postoperative weight regain was monitored (kilograms regained and duration in months). Discontinuation or dose reduction of specific medication was interpreted as remission or improvement of the main comorbidities. We excluded patients who had no proper BMI for surgery, or could not be contacted during the follow-up period.

The study was approved by the Research Ethics Committee of University of Medicine, Pharmacy, Science and Technology of Târgu Mureş.

Surgical technique

The pneumoperitoneum was performed with a Veress needle and five trocars were used. The large curvature of the stomach was dissected starting at approximately 4 cm from the pylorus to the esogastric junction. Stomach calibration was performed using a 36-Fr bougie, and the gastric sleeve was created by sequential application of staplers. Hemostasis at the level of the staple line was performed by applying metal clips. At the end of the intervention, the staple line was checked for any leaks by introducing the methylene blue solution through a nasogastric tube. The resected stomach (Figure 1) was extracted through the left port (through the 12 mm trocar place) and a drainage tube was left in place for the next 48 hours.

Figure 1

Specimen after laparoscopic sleeve gastrectomy.

Statistical analysis

Statistical calculations were performed using GraphPad Prism Software (San Diego, CA, USA) version 8 and Microsoft Office Excel. The quantitative data were presented as their means ± standard deviation (SD). Qualitative variables were expressed as frequencies and percentages. Differences between preoperative and postoperative variables were determined using the ANOVA test. The tests were interpreted as being statistically significant if the value of p was below the threshold value p=0.05.

Results

The study included 70 patients, 42 (60%) of which were women, with a mean age of 47.6 ± 9.8 years. The main clinical characteristics of the patients are included in table I.

Table I

Characteristics of study patients.

Age (years), mean ± SD	47.6 ± 9.8
Gender (F/M), n (%)	42/28 (60/40)
Weight (kg), mean ± SD	135.3 ± 22.5
BMI (kg/m2), mean ± SD	47.4 ± 6.4
Comorbidities, n (%)
Diabetes	15 (21.4)
High blood pressure	47 (67.1)
Snoring during sleep	57 (81.4)
Concomitant procedures, n (%)
Cholecystectomy	6 (8.5)
Posterior fundoplication	1 (1.4)

Legend: SD=standard deviation, BMI=body mass index.

Preoperatively, we had 27.1% patients with BMI over 50 kg/m2 and 4.2% patients with BMI over 60 kg/m2.

Concomitant procedures were performed in 6 (8.5%) patients, most of them being cholecystectomies and in 1 (1.4%) patient posterior fundoplication.

The weight loss process during follow-up, expressed as mean %EWL and mean BMI, is shown in Table II.

Table II

Weight loss after laparoscopic sleeve gastrectomy.

Years of follow-up	1	2	3	4	5	6	7	8	9	10	p
Patients	70	70	70	56	35	19	15	10	7	2
%EWL
Mean	78.2	80.2	76.7	74.7	72.8	73.3	74.1	67.2	64.1	69.7	<0.0001
SD	20.7	21.5	21.4	20.8	22.4	24.6	20.3	17.2	20.4	7.7
BMI
Mean	30.3	29.9	30.6	31.1	31.5	32.1	31.9	33.6	34.3	32.8	<0.0001
SD	5.1	4.9	5.1	5.1	5.1	6.9	6.1	6.1	7.2	1.7

Legend: %EWL=percentages of excess weight loss, SD=standard deviation, BMI=body mass index.

Weight regain occurred in 61 (87.1%) patients during the postoperative period. The mean weight regained was 8.1 ± 4.8 kg at 24 months postoperatively (range 6 – 72).

17 (24.2%) patients did not have any physical activity during the postoperative period. However 22 (30.5%) had it occasionally, and 31 (44.2%) had regular physical activity.

All patients completed the questionnaire that analyzed the quality of life after LSG. Self-esteem and sexual life were the two most favorably impacted components. In addition, self-esteem had “improved” in 83% of cases. Social life and family life were “unchanged” in 64% and 71% of cases (Figure 2).

Figure 2

Quality of life after laparoscopic sleeve gastrectomy.

On a scale from 10 to 1 (10 meaning maximum) regarding the general state of physical, mental and emotional well-being, 29 (41.4%) of patients chose 10, while 3 (4.2%) chose 5. The rest of the patients were located between these values (Figure 3). There were no grades below 5.

Figure 3

Scale for general state of physical, mental and emotional well-being.

Of the common obesity-related comorbidities, diabetes was found in 15 (21.4%) patients, followed by high blood pressure that was found in 47 (67.1%) patients; 57 (81.4%) reported snoring during sleep. Table III shows the resolution of comorbidities after LSG.

Table III

Resolution of comorbidities after laparoscopic sleeve gastrectomy

Obesity-related comorbidities	Before LSG	Resolution
Diabetes	15	12 (80%)
High blood pressure	47	20 (42.5%)
Snoring during sleep	57	40 (70.1%)

Legend: LSG=laparoscopic sleeve gastrectomy.

Discussion

In recent years, with the rise of the obesity epidemic, LSG has evolved as a primary bariatric procedure and is currently recognized by most authors as the most widespread method [8]. There are published randomized trials [12,13] which confirm that LSG is a safe and effective procedure for weight loss and resolution of major comorbidities.

However, issues such as long-term reporting of LSG results remain to be discussed. There are studies in the western countries that approach this subject [14,15], but not the same can be said about the eastern part of Europe. Through this study we show, in a retrospective manner, the experience of a single surgical department from Târgu Mureş, Romania, in which we analyze the postoperative outcomes of LSG in the medium and long term.

This study supports the fact that LSG is an effective way to lose weight. The results of our study are comparable to other publications [16,17]. The randomized clinical trial published by Kehagias et al. [18] report a %EWL after LSG of 72.9% at 12 months, 73.2% and 68.5% at 24 and 36 months, respectively.

The reason why a tendency for weight regain is seen remains unknown because the evolution of the gastric tube over time is not fully elucidated and the mechanism of weight regain is still unclear. Weight regain occurred in 61 (87.1%) patients of our series, however, the average of the regained kilograms was only 8 kg, after an average postoperative period of 2 years. Fahmy et al. [19] studied this mechanism and concluded that the gained kilograms are positively correlated with the distance between the pylorus and the start of the staple line. We applied the same technique to all patients and we started with the staple line approximately 4 cm from the pylorus. This distance could be considered a hypothesis in the mechanism of weight regain. Another hypothesis could be that patients have low compliance with regular visits postoperatively. Once these patients lose weight initially, they do not return for long-term follow-up, compared to patients in western countries. It was published that the lack of postoperative visits after bariatric surgery was associated with poor weight loss and weight regain [20]. At the same time, lack of physical activity and keeping old eating habits can harm weight maintenance. Our results show that 44.2% of patients regularly performed physical activity after surgery, while 24.2% did not. Other hypotheses, such as dilatation of the gastric tube or insufficient resection of the gastric fundus (place where the ghrelin is secreted) [21] could also be discussed. In a review by Karmali et al. [22] they concluded that there is a multifactorial cause that leads to weight regain, with surgical intervention and patient dependent factors, respectively.

Obesity is a disease not only through the risk of associated comorbidities but it is also cause of daily difficulties, leading to a decrease in QoL. Surgical treatment of obesity in addition to improving the QoL offers the individual a social, family, emotional and psychological reintegration [23,24]. Changes in self-image and self-esteem after bariatric surgery have a positive influence on QoL [25]. In our patients, in 83% of cases, self-esteem after LSG increased. Social life and family life were “unchanged” in 64% and 71% of cases. On a scale from 10 to 1 (10 meaning maximum) regarding the general state of physical, mental and emotional well-being, 41.4% of the patients chose the maximum note 10, and 4.2% chose the note 5, the rest being between these intervals. There were no grades below 5. These data come to support the increase in QoL after LSG and therefore success after bariatric surgery should include not only weight loss and resolution of comorbidities but also improvements in QoL.

Similar to other studies [26,27], we have also shown remission, namely improvement of comorbidities. Diabetes recovered, respectively improved in 80% of cases. Seven (46.6%) patients gave up oral antidiabetics, and 5 (33.3%) patients switched from insulin to oral antidiabetics. According to Juodeikis et al. [28] in a review that analyzes the long-term results after LSG, diabetes recovered in of 77.8% of the population studied.

In the case of high blood pressure, we showed that 42.5% of the cases showed remission, respectively improvement. Six (12.7%) patients gave up antihypertensive medication, while 14 (29.7%) reduced the dose. Casella et al. [29] report high blood pressure improvement in 38.8% of cases. In a review of 14 studies, Graham et al. [30] show that the data on remission and/or improvement of high blood pressure are heterogeneous, due to the fact that there is no standardization of the definitions of remission/improvement and also the existence of the small number of studies analyzing the results of hypertension after LSG.

Castagneto et al. [15] report sleep apnea remission in 72.2% of cases. In our study, the percentage was 70.1%, but it was a subjective interpretation characterized by the lack of snoring during sleep.

There are several limitations to our study. The first limitation is represented by the retrospective manner of the study. A complete follow-up was effective only for 70 patients, which leads to the second limitation, represented by the relatively small number of patients enrolled and the single department characteristic of the investigation. Nevertheless, the current literature research indicates that the number of included cases may be statistically sufficient to draw conclusions [31,32]. The third one is given by the fact that the outcomes were collected by telephone. The fourth could be considered a limitation, because in our department we used only LSG as surgical technique for the treatment of obesity and because of that we could not compare our outcomes with other bariatric techniques outcomes.

Conclusions

Following the results of the study, we can consider LSG as an effective bariatric procedure in the fight against obesity. The medium and long-term follow-up shows a tendency to weight regain after approximately 2 years. After LSG, a resolution of the comorbidities takes place, respectively the QoL improves. With this study, we contribute with additional information regarding the results of LSG in the medium and long term, in Eastern Europe, particularly in Romania, and we consider that the implementation of a national bariatric surgical program is required in our country.